Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of APD418. A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to
Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of APD418 in Subjects with Heart Failure with Reduced Ejection Fraction.